Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation "ASAP-TOO"

Recruiting

Phase N/A Results N/A

Summary of Purpose

The purpose of this study is to establish the safety and effectiveness of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device, including the post-implant medication regimen, for subjects with non-valvular atrial fibrillation who are deemed not to be eligible for anti-coagulation therapy to reduce the risk of stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 June 2017.

1 Feb 2017 5 Oct 2016 1 Dec 2023 1 Dec 2023 1 Mar 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts